ABVC BioPharma, Inc. announced that at its annual meeting of shareholders held on May 20, 2022, elected Che Wei Hsu, Shuling Jiang and Kuang-Tseng Chen as directors to the Company's Board, with such directors to serve until the 2023 annual meeting of shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.08 USD | -6.09% | -23.94% | -6.90% |
1st Jan change | Capi. | |
---|---|---|
-6.90% | 11.38M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- ABVC Stock
- News ABVC BioPharma, Inc.
- ABVC BioPharma, Inc. Announces Board Elections